Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice

Hypertension

Volumn 57, Issue 3 PART 2, 2011, Pages 600-607

  Grobe, Justin L ^a   Buehrer, Beth A ^a   Hilzendeger, Aline M ^a   Liu, Xuebo ^a   Davis, Deborah R ^a   Xu, Di ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

hypertension; metabolism; mineralocorticoid; salt; sympathetic nervous activity

Indexed keywords

DEOXYCORTICOSTERONE; LOSARTAN; POTASSIUM; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; FOOD INTAKE; HYPERTENSION; MALE; MOUSE; NONHUMAN; POLYDIPSIA; POLYURIA; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM URINE LEVEL; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANGIOTENSINS; ANIMALS; BASAL METABOLISM; BLOOD PRESSURE; BRAIN; CALORIMETRY; DESOXYCORTICOSTERONE; EATING; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; RENIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SODIUM, DIETARY; STATISTICS, NONPARAMETRIC;

EID: 79953191408     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.165829     Document Type: Article

References (29)

1. Laragh JH. Biochemical profiling and the natural history of hypertensive diseases: low-renin essential hypertension, a benign condition. Circulation. 1971;44:971-974.
2. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res. 1998;39:77-88. (Pubitemid 28322381)
3. Selye H, Hall CE, Rowley EM. Malignant hypertension produced by treatment with desoxycorticosterone acetate and sodium chloride. Can Med Assoc J. 1943;49:88-92.
4. Goodwin FJ, Knowlton AI, Laragh JH. Absence of renin suppression by deoxycorticosterone acetate in rats. Am J Physiol. 1969;216:1476-1480.
5. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res. 1975;36:300-309.
6. Makrides SC, Mulinari R, Zannis VI, Gavras H. Regulation of renin gene expression in hypertensive rats. Hypertension. 1988;12:405-410.
7. Nishimura M, Ohtsuka K, Iwai N, Takahashi H, Yoshimura M. Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels. Am J Physiol. 1999;276:R1416-R1424. (Pubitemid 29249667)
8. Schenk J, McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods. 1992;27:161-170.
9. Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol. 1986;251:H261-H268.
10. Kubo T, Yamaguchi H, Tsujimura M, Hagiwara Y, Fukumori R. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats. Hypertens Res. 2000;23:109-118. (Pubitemid 30326234)
11. Park CG, Leenen FH. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. J Korean Med Sci. 2001;16: 553-537.
12. Palkovits M, Záborszky L. Neuroanatomy of central cardiovascular control: nucleus tractus solitarii: afferent and efferent neuronal connections in relation to the baroreceptor reflex arc. Prog Brain Res. 1977;47:9-34.
13. Mangiapane ML, Simpson JB. Subfornical organ lesions reduce the pressor effect of systemic angiotensin II. Neuroendocrinology. 1980;31: 380-384. (Pubitemid 11250985)
14. Casto R, Phillips MI. Mechanism of pressor effects by angiotensin in the nucleus tractus solitarius of rats. Am J Physiol. 1984;247:R575-R581. (Pubitemid 14003649)
15. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol. 1988;255: H646-H650.
16. Campión J, Lahera V, Cachofeiro V, Maestro B, Dávila N, Carranza MC, Calle C. In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess. Mol Cell Biochem. 1998;185:177-182. (Pubitemid 28408509)
17. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metabolism. 2010;12:431-442.
18. Porter JP, Anderson JM, Robison RJ, Phillips AC. Effect of central angiotensin II on body weight gain in young rats. Brain Res. 2003;959: 20-28. (Pubitemid 35435402)
19. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004;287:R422-R428. (Pubitemid 38970297)
20. Massiera F, Seydoux J, Geloen A, Quignard-Boulange A, Turban S, Saint-Marc P, Fukamizu A, Negrel R, Ailhaud G, Teboul M. Angiotensinogen- deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology. 2001;142:5220-5225. (Pubitemid 33131951)
21. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M, Hirata Y, Ogawa Y. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1A receptor. Endocrinology. 2005;146:3481-3489. (Pubitemid 41065022)
22. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes. 2005;54:991-999. (Pubitemid 40446313)
23. Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR. Eur J Pharmacol. 2006;552:112-122. (Pubitemid 44754970)
24. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA. 2008;105:6531-6536. (Pubitemid 351754541)
25. Carter CS, Cesari M, Ambrosius WT, Hu N, Diz D, Oden S, Sonntag WE, Pahor M. Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats. J Gerontol A Biol Sci Med Sci. 2004;59:416-423. (Pubitemid 38649931)
26. Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR, Bartness TJ, Kim HS, Harp JB. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 2007;6:506-512. (Pubitemid 350163052)
27. Stucchi P, Cano V, Ruiz-Gayo M, Fernández-Alfonso MS. Aliskiren reduces body-weight gain, adiposity and plasma leptin during dietinduced obesity. Br J Pharmacol. 2009;158:771-778.
28. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, Sinclair AJ, Wark JD, Weisinger RS. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav. 2008;93:820-825. (Pubitemid 351381081)
29. Yemane H, Busauskas M, Burris SK, Knuepfer MM. Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Exp Physiol. 2010;91:51-55.